AGREE II Item number | Median Question Rating (Likert scale from 1 to 7) | ||
---|---|---|---|
Domain 3. Rigour of Development | Phase 1 original (15 CPGs) | Phase 2 origina (15 CPGs) | Phase 2 updated (15 CPGs) |
7. Systematic methods were used to search for evidence | 1 | 1 | 6 |
8. The criteria for selecting the evidence are clearly described | 1 | 1 | 6 |
9. The strengths and limitations of the body of evidence are clearly described | 4 | 2 | 3 |
10. The methods for formulating the recommendations are clearly described | 5 | 5 | 6 |
11. The health benefits, side effects, and risks have been considered in formulating the recommendations | 7 | 4 | 5 |
12. There is an explicit link between the recommendations and the supporting evidence | 5 | 5 | 6 |
13. The guideline has been externally reviewed by experts prior to its publication | 6 | 5 | 6 |
14. A procedure for updating the guideline is provided | 4 | 3 | 6 |
Overall assessment question | Phase 1 original (15 CPGs) | Phase 2 original (15 CPGs) | Phase 2 updated (15 CPGs) |
1. Rate the overall quality of this guideline | 5 | 5 | 6 |